U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), By Modality (Nuclear Imaging, CT scans), By Application (Breast Cancer, Lung Cancer), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Modality
                       1.2.3. Application
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in U.S.
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Type outlook
                       2.2.2. Modality outlook
                       2.2.3. Application outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Cancer Contrast Media Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing number of clinical studies
                           3.2.1.2. Rising cancer cases
                           3.2.1.3. Technological advancements
                       3.2.2. Market restraint analysis
                           3.2.2.1. Side effects and adverse reactions related to contrast agents
                           3.2.2.2. Presence of alternative imaging options
                       3.2.3. Market opportunity analysis
                           3.2.3.1. Increasing demand for medical imaging
                       3.2.4. Market challenges analysis
                           3.2.4.1. Shortage of contrast media due to supply chain disruptions
                   3.3. U.S. Cancer Contrast Media Market: Regulatory Framework and Standards & Compliances
                   3.4. U.S. Cancer Contrast Media Market: Reimbursement Scenario
                   3.5. U.S. Cancer Contrast Media Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s Five Forces
                           3.5.1.1. Supplier power
                           3.5.1.2. Buyer power
                           3.5.1.3. Substitution threat
                           3.5.1.4. Threat of new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political landscape
                           3.5.2.2. Technological landscape
                           3.5.2.3. Economic landscape
Chapter 4. U.S. Cancer Contrast Media Market: Type Estimates & Trend Analysis
                   4.1. Type Market Share, 2023 & 2030
                   4.2. Segment Dashboard
                   4.3. U.S. Cancer Contrast Media Market by Type Outlook
                   4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.4.1. Gadolinium-based Contrast Media
                           4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.2. Iodinated Contrast Media
                           4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.3. Radioactive Agents
                           4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.4. Others
                           4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Cancer Contrast Media Market: Modality Estimates & Trend Analysis
                   5.1. Modality Market Share, 2023 & 2030
                   5.2. Segment Dashboard
                   5.3. U.S. Cancer Contrast Media Market by Modality Outlook
                   5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.4.1. Nuclear Imaging
                           5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.2. CT scans
                           5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.3. Mammography
                           5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.4. MRI scans
                           5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.5. Ultrasound
                           5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Cancer Contrast Media Market: Application Estimates & Trend Analysis
                   6.1. Application Market Share, 2023 & 2030
                   6.2. Segment Dashboard
                   6.3. U.S. Cancer Contrast Media Market by Application Outlook
                   6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.4.1. Breast Cancer
                           6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.2. Bladder Cancer
                           6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.3. Colorectal Cancer
                           6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.4. Lung Cancer
                           6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.5. Prostate Cancer
                           6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.6. Others
                           6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Vendor Landscape
                       7.3.1. List of key distributors and channel partners
                       7.3.2. Key customers
                       7.3.3. Key company market share analysis, 2023
                       7.3.4. Bayer AG
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.4.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Lantheus
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. Bracco
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. Guerbet
                           7.3.7.1. Company overview
                           7.3.7.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.7.4. Strategic initiatives
                       7.3.8. Trivitron Healthcare
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. Cardinal Health
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. Telix Pharmaceuticals Limited
                           7.3.10.1. Company overview
                           7.3.10.2. Financial performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. GE HealthCare
                           7.3.11.1. Company overview
                           7.3.11.2. Financial performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives
                       7.3.12. IMAX Diagnostic Imaging
                           7.3.12.1. Company overview
                           7.3.12.2. Financial performance
                           7.3.12.3. Product benchmarking
                           7.3.12.4. Strategic initiatives
                       7.3.13. Nano Therapeutics Pvt. Ltd.
                           7.3.13.1. Company overview
                           7.3.13.2. Financial performance
                           7.3.13.3. Product benchmarking
                           7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. cancer contrast media market, by type, 2018 - 2030 (USD Million)
Table 3 U.S. cancer contrast media market, by modality, 2018 - 2030 (USD Million)
Table 4 U.S. cancer contrast media market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in U.S.
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. cancer contrast media market: market outlook
Fig. 10 U.S. cancer contrast media competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. cancer contrast media market driver impact
Fig. 16 U.S. cancer contrast media market restraint impact
Fig. 17 U.S. cancer contrast media market strategic initiatives analysis
Fig. 18 U.S. cancer contrast media market: Type movement analysis
Fig. 19 U.S. cancer contrast media market: Type outlook and key takeaways
Fig. 20 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030
Fig. 21 Iodinated contrast media estimates and forecast, 2018 - 2030
Fig. 22 Radioactive agents market estimates and forecast, 2018 - 2030
Fig. 23 Others estimates and forecast, 2018 - 2030
Fig. 24 U.S. cancer contrast media Market: Modality movement Analysis
Fig. 25 U.S. cancer contrast media market: Modality outlook and key takeaways
Fig. 26 Nuclear imaging market estimates and forecasts, 2018 - 2030
Fig. 27 CT scans market estimates and forecasts, 2018 - 2030
Fig. 28 Mammography market estimates and forecasts, 2018 - 2030
Fig. 29 MRI scans market estimates and forecasts, 2018 - 2030
Fig. 30 Ultrasound market estimates and forecasts, 2018 - 2030
Fig. 31 U.S. cancer contrast media market: Application movement analysis
Fig. 32 U.S. cancer contrast media market: Application outlook and key takeaways
Fig. 33 Colorectal cancer market estimates and forecasts, 2018 - 2030
Fig. 34 Bladder cancer market estimates and forecasts, 2018 - 2030
Fig. 35 Breast cancer market estimates and forecasts, 2018 - 2030
Fig. 36 Lung cancer market estimates and forecasts, 2018 - 2030
Fig. 37 Prostate cancer market estimates and forecasts, 2018 - 2030
Fig. 38 Other market estimates and forecasts, 2018 - 2030
Fig. 39 Market share of key market players - U.S. cancer contrast media market
Fig. 40 Key company categorization
Fig. 41 Company market positioning
Fig. 42 Key company market share analysis, 2023
Fig. 43 Strategic framework